静脉炎颗粒治疗血栓性浅静脉炎急性期(血热瘀结证)有效性和安全性的随机、双盲、安慰剂对照、剂量探索、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, dose-finding, multicenter phase II clinical trial on the efficacy and safety of phlebitis granules in the treatment of acute superficial thrombophlebitis (blood heat and stasis syndrome)
1. 初步评价静脉炎颗粒治疗血栓性浅静脉炎急性期(血热瘀结证)的有效性及安全性;
2. 探索静脉炎颗粒治疗血栓性浅静脉炎急性期(血热瘀结证)的临床剂量与临床效应关系,为下一步临床试验提供依据。
[Translation] 1. To preliminarily evaluate the effectiveness and safety of phlebitis granules in the treatment of acute stage of superficial thrombophlebitis (blood heat and stasis syndrome);
2. To explore the relationship between clinical dose and clinical effect of phlebitis granules in the treatment of acute stage of superficial thrombophlebitis (blood heat and stasis syndrome), and provide a basis for the next clinical trial.
100 Clinical Results associated with Shanghai Tufeng Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Shanghai Tufeng Pharmaceutical Technology Co., Ltd.
100 Deals associated with Shanghai Tufeng Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Shanghai Tufeng Pharmaceutical Technology Co., Ltd.